Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $23.34 USD
Change Today -0.35 / -1.48%
Volume 36.8K
SRDX On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 06/29/15 All times are local (Market data is delayed by at least 15 minutes).

surmodics inc (SRDX) Snapshot

Open
$23.48
Previous Close
$23.69
Day High
$23.84
Day Low
$23.09
52 Week High
04/15/15 - $27.36
52 Week Low
10/1/14 - $18.00
Market Cap
303.7M
Average Volume 10 Days
67.3K
EPS TTM
$0.95
Shares Outstanding
13.0M
EX-Date
--
P/E TM
24.6x
Dividend
--
Dividend Yield
--
Current Stock Chart for SURMODICS INC (SRDX)

surmodics inc (SRDX) Related Bloomberg News

View More Bloomberg News

surmodics inc (SRDX) Related Businessweek News

No Related Businessweek News Found

surmodics inc (SRDX) Details

SurModics, Inc. provides surface modification and in vitro diagnostic technologies to the healthcare industry. The company operates through two segments, Medical Device and In Vitro Diagnostics. The Medical Device segment offers surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device for the coronary, peripheral, neurovascular, urology, and other markets. The In Vitro Diagnostics segment provides component products and technologies that include protein stabilization reagents, substrates, antigens, and surface coatings for diagnostic immunoassay and molecular tests, and biomedical research applications. SurModics, Inc. markets its technologies and products worldwide through direct sales force consisting of sales professionals. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

120 Employees
Last Reported Date: 12/5/14
Founded in 1979

surmodics inc (SRDX) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $443.7K
Chief Financial Officer and Vice President of...
Total Annual Compensation: $252.2K
Senior Vice President and General Manager of ...
Total Annual Compensation: $285.6K
Senior Vice President of Legal & Human Resour...
Total Annual Compensation: $285.6K
Vice President of Corporate Development & Str...
Total Annual Compensation: $266.5K
Compensation as of Fiscal Year 2014.

surmodics inc (SRDX) Key Developments

SurModics, Inc. Presents at Jefferies 2015 Global Healthcare Conference, Jun-03-2015 08:30 AM

SurModics, Inc. Presents at Jefferies 2015 Global Healthcare Conference, Jun-03-2015 08:30 AM. Venue: The Grand Hyatt Hotel, New York, New York, United States. Speakers: Andrew D.C. LaFrence, Chief Financial Officer and Vice President of Finance, Gary R. Maharaj, Chief Executive Officer, President and Director.

SurModics, Inc. Presents at The Benchmark Company, LLC OneonOne Investor Conference, May-28-2015

SurModics, Inc. Presents at The Benchmark Company, LLC OneonOne Investor Conference, May-28-2015 . Venue: The Pfister Hotel, 424 E. Wisconsin Avenue, Milwaukee, Wisconsin, United States.

SurModics, Inc. Announces Unaudited Consolidated Earnings Results for Second Quarter and Six Months Ended March 31, 2015; Reaffirms Earnings Guidance for Full Year 2015

SurModics, Inc. announced unaudited consolidated earnings results for second quarter and six months ended March 31, 2015. For the quarter, the company reported total revenue of $14,415,000, operating income of $3,932,000, income before income taxes of $4,531,000, net income of $3,051,000 or $0.23 diluted per share, compared to the total revenue of $13,604,000, operating income of $3,480,000, income before income taxes of $3,671,000, net income of $2,459,000 or $0.18 diluted per share, for the same quarter a year ago. For the year to date, the company reported total revenue of $28,620,000, operating income of $8,966,000, income before income taxes of $9,615,000, net income of $6,665,000 or $0.5 diluted per share, net cash provided by operating activities from continuing operations of $6,830,000, purchases of property and equipment of $163,000 compared to the total revenue of $27,487,000, operating income of $7,809,000, income before income taxes of $8,767,000, net income of $6,089,000 or $0.44 diluted per share, net cash provided by operating activities from continuing operations of $5,936,000, purchases of property and equipment of $798,000 for the same period a year ago. The company is reaffirming its previously stated revenue, earnings per share and operating cash flow guidance for fiscal 2015. The company expects full-year revenue to be in the range of $57.0 million to $60.0 million, and diluted GAAP earnings to be in the range of $0.85 per share to $0.95 per share. Income tax rate to be in the range of 33.0% to 35.0%. GAAP cash flow from operating activities is expected to range between $16.5 million and $18.0 million for fiscal 2015, unchanged from prior guidance. The company lowering its planned capital expenditures estimate for fiscal 2015 to a range between $1.7 million and $2.2 million, compared to previous guidance of $2.2 million to $2.5 million.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SRDX:US $23.34 USD -0.35

SRDX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Novartis AG SFr.92.05 CHF -0.25
Regeneron Pharmaceuticals Inc $504.97 USD -15.66
View Industry Companies
 

Industry Analysis

SRDX

Industry Average

Valuation SRDX Industry Range
Price/Earnings 25.2x
Price/Sales 5.2x
Price/Book 3.6x
Price/Cash Flow 24.4x
TEV/Sales 4.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SURMODICS INC, please visit www.surmodics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.